FI55502B - Foerfarande foer framstaellning av trombos foerhindrande 4-amino-6-arylpyrimidiner - Google Patents

Foerfarande foer framstaellning av trombos foerhindrande 4-amino-6-arylpyrimidiner

Info

Publication number
FI55502B
FI55502B FI2734/71A FI273471A FI55502B FI 55502 B FI55502 B FI 55502B FI 2734/71 A FI2734/71 A FI 2734/71A FI 273471 A FI273471 A FI 273471A FI 55502 B FI55502 B FI 55502B
Authority
FI
Finland
Prior art keywords
arylpyrimidines
amino
procedure
frame station
station
Prior art date
Application number
FI2734/71A
Other languages
English (en)
Other versions
FI55502C (fi
Inventor
Gerald George De Angelis
Hans-Jurgen Ernst Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to FI773287A priority Critical patent/FI55834C/fi
Publication of FI55502B publication Critical patent/FI55502B/fi
Application granted granted Critical
Publication of FI55502C publication Critical patent/FI55502C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI2734/71A 1970-10-05 1971-09-30 Foerfarande foer framstaellning av trombos foerhindrande 4-amino-6-arylpyrimidiner FI55502C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI773287A FI55834C (fi) 1970-10-05 1977-11-02 Foerfarande foer framstaellning av 4-hydroxi-5-etyl-6-fenylpyrimidin med bronchodilaterande verkan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7821670A 1970-10-05 1970-10-05

Publications (2)

Publication Number Publication Date
FI55502B true FI55502B (fi) 1979-04-30
FI55502C FI55502C (fi) 1979-08-10

Family

ID=22142671

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2734/71A FI55502C (fi) 1970-10-05 1971-09-30 Foerfarande foer framstaellning av trombos foerhindrande 4-amino-6-arylpyrimidiner

Country Status (16)

Country Link
US (1) US3707560A (fi)
JP (2) JPS5648511B1 (fi)
AT (4) AT315856B (fi)
AU (1) AU465734B2 (fi)
BE (1) BE773484A (fi)
CA (1) CA988519A (fi)
CH (4) CH554346A (fi)
DE (2) DE2165962C2 (fi)
DK (1) DK131858C (fi)
ES (4) ES395676A1 (fi)
FI (1) FI55502C (fi)
FR (1) FR2110227B1 (fi)
GB (2) GB1373536A (fi)
NL (1) NL168511C (fi)
SE (2) SE385885B (fi)
ZA (1) ZA716615B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
US3895112A (en) * 1970-10-05 1975-07-15 Pfizer Arylpyrimidines in the relaxation of smooth muscle
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US3835132A (en) * 1972-02-01 1974-09-10 Shell Oil Co Morpholino-piperazinyl pyrimidines
US3950525A (en) * 1973-06-19 1976-04-13 Pfizer Inc. Relaxation of smooth muscle in a mammal
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
US4725600A (en) * 1984-07-13 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent
JPH0625157B2 (ja) * 1988-01-29 1994-04-06 宇部興産株式会社 4―ヒドロキシピリミジン類の製造方法
US4935516A (en) * 1988-01-29 1990-06-19 Ube Industries, Ltd. Process for preparing 4-hydroxypyrimidine
DE3825647A1 (de) * 1988-07-28 1990-02-01 Geyer Gmbh & Co Christian Vorrichtung zur befestigung eines elektrischen schaltgeraetes
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
DE60005355T2 (de) * 1999-07-15 2004-07-01 Pharmacopeia, Inc. Bradikinin b1 rezeptor antagonisten
WO2003077656A1 (en) * 2002-03-15 2003-09-25 Ciba Specialty Chemicals Holding Inc. 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
CA2486376A1 (en) * 2002-05-22 2003-12-04 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
JP2006521345A (ja) * 2003-03-28 2006-09-21 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ニコチン性アセチルコリン受容体の正のアロステリック調節剤
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
JP2009164373A (ja) * 2008-01-08 2009-07-23 Toshiba Corp 半導体装置
EP2528441A4 (en) * 2010-01-25 2013-07-10 Chdi Foundation Inc CERTAIN KYNURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
SG2014011654A (en) 2011-08-30 2014-08-28 Chdi Foundation Inc Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012302144B2 (en) 2011-08-30 2017-06-15 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CA2955379C (en) 2014-07-17 2022-12-13 Chdi Foundation, Inc. Methods and compositions for treating hiv-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047462A (en) * 1959-03-06 1962-07-31 Lab Jacques Logeais Soc D Expl Quinazolone anti-inflammatory composition

Also Published As

Publication number Publication date
SE385885B (sv) 1976-07-26
DE2149249A1 (de) 1972-04-13
BE773484A (fr) 1972-04-05
ES420211A1 (es) 1976-03-16
NL7113670A (fi) 1972-04-07
AU465734B2 (en) 1975-10-09
ES420209A1 (es) 1976-06-01
JPS578107B2 (fi) 1982-02-15
AT317229B (de) 1974-08-26
CA988519A (en) 1976-05-04
CH554346A (fr) 1974-09-30
AU3425971A (en) 1973-04-12
GB1373535A (en) 1974-11-13
FR2110227B1 (fi) 1975-02-07
JPS5636468A (en) 1981-04-09
AT315856B (de) 1974-05-15
SE390304B (sv) 1976-12-13
NL168511B (nl) 1981-11-16
ZA716615B (en) 1972-06-28
DK131858B (da) 1975-09-15
ES395676A1 (es) 1974-10-16
CH554875A (fr) 1974-10-15
DE2165962A1 (de) 1972-08-31
DE2165962C2 (de) 1982-05-13
CH542218A (fr) 1973-11-15
DE2149249B2 (de) 1974-11-07
AT314540B (de) 1974-04-10
JPS5648511B1 (fi) 1981-11-16
CH554876A (fr) 1974-10-15
NL168511C (nl) 1982-04-16
US3707560A (en) 1972-12-26
GB1373536A (en) 1974-11-13
AT316563B (de) 1974-06-15
FR2110227A1 (fi) 1972-06-02
DE2149249C3 (de) 1975-07-03
ES420210A1 (es) 1976-06-01
DK131858C (da) 1976-02-16
SE7410488L (fi) 1974-08-16
FI55502C (fi) 1979-08-10

Similar Documents

Publication Publication Date Title
FI53940C (fi) Foerfarande och anordning foer framstaellning av en polymerskumstroem
ES203624Y (es) Armazon de entramado.
FI55502C (fi) Foerfarande foer framstaellning av trombos foerhindrande 4-amino-6-arylpyrimidiner
BG20582A3 (bg) Метод за получаване на р-халоген-фенил-2-пиромидинони
SE388422B (sv) Forfarande for reduktion av theabin
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
AT332624B (de) Zarge
TR16847A (tr) Mikrogranuelatlarin yapilmasina mahsus usul
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
FI56043B (fi) Foerfarande foer framstaellning av roekningsaemne
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE7511913L (sv) Forfarande for att framstella wellpapp
SE373572B (sv) Forfarande for framstellning av pyroglutamyl-histidyl-prolinamid
BG19133A3 (bg) Метод за получаване на 1-фенил-2-хидрокси-3-хидроксилалкиламинопропани
SU439963A3 (ru) Способ получения фениламиноалканов
SE380528B (sv) Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat
SE380795B (sv) Forfarande for framstellning av tiokarbamider
FI55509C (fi) Foerfarande foer framstaellning av indolderivat med antiinflammatoriska egenskaper
FI53441C (fi) Anordning foer omlastning av godbehaollare
BG20586A3 (bg) Метод за получаване на заместени n-хидрокси-алкил-2-ариламино-имидазолини
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol
SE386676B (sv) Forfarande for framstellning av tropan-3-ol-derivat
SE382320B (sv) Forfarande for framstellning av diamanter
SU437283A3 (ru) Способ получения производных пиридинкарбамата